Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -70.85% is 23% below its 5-year average of -57.76%, near the high end of its 5-year range (-183.23%–-29.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.23% above its 12-month average of -92.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -70.85%.
RETURN ON EQUITY (ROE)
-70.85%
RETURN ON EQUITY (ROE) AVG TTM
-92.28%
RETURN ON EQUITY (ROE) AVG 3Y
-72.30%
RETURN ON EQUITY (ROE) AVG 5Y
-57.76%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.23%
CURRENT VS 3Y AVG
+2.01%
CURRENT VS 5Y AVG
-22.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-68.64%
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.19B
Return on Equity (ROE)
-70.85%
TTM Avg
-92.28%
3Y Avg
-72.30%
5Y Avg
-57.76%
Market Cap
$5.20B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$5.20B
Return on Equity (ROE)
24.56%
TTM Avg
11.91%
3Y Avg
-7.82%
5Y Avg
-3.31%
Market Cap
$5.21B
Return on Equity (ROE)
-177.24%
TTM Avg
-283.26%
3Y Avg
-317.97%
5Y Avg
-235.28%
Market Cap
$5.21B
Return on Equity (ROE)
-25.83%
TTM Avg
-24.61%
3Y Avg
-23.01%
5Y Avg
-16.21%
Market Cap
$5.09B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
Market Cap
$5.07B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$5.32B
Return on Equity (ROE)
N/A
TTM Avg
-149.71%
3Y Avg
-15.45%
5Y Avg
-6097.55%
Market Cap
$5.06B
Return on Equity (ROE)
3.38%
TTM Avg
1.14%
3Y Avg
-0.67%
5Y Avg
-0.98%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.19B | -70.85% | -92.28% | -72.30% | -57.76% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 18.24% | 20.62% | 17.32% | 27.02% |
| Sotera Health Company (SHC)vs › | $5.20B | 24.56% | 11.91% | -7.82% | -3.31% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | -177.24% | -283.26% | -317.97% | -235.28% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -25.83% | -24.61% | -23.01% | -16.21% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | -161.00% | -110.38% | -86.51% | -75.97% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 8.67% | 8.42% | 7.80% | 5.80% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | N/A | -149.71% | -15.45% | -6097.55% |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 3.38% | 1.14% | -0.67% | -0.98% |
| Erasca, Inc. (ERAS)vs › | $4.96B | -79.37% | -38.23% | -43.73% | -49.41% |
ROE
-70.8%
ROA
-45.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -70.85% |
| 2026-03-31 | -58.30% |
| 2025-12-31 | -51.69% |
| 2025-09-30 | -97.32% |
| 2025-06-30 | -183.23% |
| 2025-03-31 | -123.06% |
| 2024-12-31 | -99.83% |
| 2024-09-30 | -77.00% |
| 2024-06-30 | -60.83% |
| 2024-03-31 | -50.24% |
| 2023-12-31 | -74.63% |
| 2023-09-30 | -58.65% |
| 2023-06-30 | -45.16% |
| 2023-03-31 | -66.29% |
| 2022-12-31 | -54.84% |
| 2022-09-30 | -43.30% |
| 2022-06-30 | -34.30% |
| 2022-03-31 | -48.53% |
| 2021-12-31 | -33.74% |
| 2021-09-30 | -29.76% |
| 2021-06-30 | -42.10% |
| 2021-03-31 | -35.47% |
| 2020-12-31 | -31.88% |
| 2020-09-30 | -52.71% |
| 2020-06-30 | -120.12% |
| 2020-03-31 | -102.08% |
| 2019-12-31 | -100.22% |
| 2019-09-30 | -149.31% |
| 2019-06-30 | -103.08% |
| 2019-03-31 | -80.11% |
| 2018-12-31 | -57.33% |
| 2018-09-30 | -48.30% |
| 2018-06-30 | -38.41% |
| 2018-03-31 | -165.35% |
| 2017-12-31 | -90.06% |
